DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
US patients pay 3-10x more than UK, EU, or Australia. Here is the per-country pricing, supply state, and route-to-prescription for the seven largest GLP-1 markets.
Manufacturer direct cash-pay is the price floor. Commercial insurance variable. Medicare cardiovascular pathway opened 2026.
NHS weight-loss prescribing extremely restrictive. Private clinics (Boots Online Doctor, LloydsPharmacy Online) are the dominant route.
Provincial drug plans vary widely (Ontario, BC, Quebec each different). T2D coverage standard; weight-loss patchy.
PBS does not cover weight-loss GLP-1s. Private prescriptions through specialist endocrinology clinics dominate.
Lebensstilmedikamente (lifestyle medications) generally excluded from statutory coverage. Private route via online clinics growing.
Sécurité Sociale does not cover GLP-1 for weight loss. Médecin traitant referral typically required for private GLP-1 scripts.
Sistema Nacional de Salud does not cover weight-loss GLP-1s. Private endocrinology clinics dominant.
Editorial summary, last reviewed 2026-05. Prices and supply shift; verify with local prescriber and pharmacy. Importing prescription medication across borders is illegal for personal use in most jurisdictions.